Rocket One Inc. Cash and Restricted Cash
Rocket One Inc. (RKTO) had Cash and Restricted Cash of $7.89 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.89M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.05M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.25M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.85M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $7.89M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.05M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $6.25M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $7.85M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $9.01M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $11.32M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $7.04M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $8.02M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $9.65M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $7.56M 10-Q · filed 2025-05-12 |
| 2023-12-31 | $9.29M 10-K · filed 2026-03-27 |
| 2023-09-30 | $11.83M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $11.54M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $13.04M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $6.43M 10-K · filed 2025-03-28 |
| 2022-09-30 | $8.94M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $11.32M 10-Q · filed 2023-08-11 |
| 2022-03-31 | $6.38M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $8.54M 10-K · filed 2024-03-28 |
| 2021-09-30 | $12.45M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $15.85M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $19.30M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $2.63M 10-K · filed 2023-03-31 |
| 2020-09-30 | $4.12M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $4.95M 10-Q · filed 2021-08-11 |
| 2020-03-31 | $4.55M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $1.89M 10-K · filed 2022-03-30 |
| 2019-09-30 | $3.41M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $4.29M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $5.37M 10-Q · filed 2020-05-13 |
| 2018-12-31 | $282.62K 10-K · filed 2021-03-16 |
| 2018-09-30 | $737.68K 10-Q · filed 2019-11-12 |
| 2018-06-30 | $1.47M 10-Q · filed 2019-08-14 |
| 2017-12-31 | $1.23M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |